Search Result "Pertuzumab"
Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
Journal: Current Drug Metabolism
Volume: 13 Issue: 7 Year: 2012 Page: 911-922
Author(s): Dan Lu,Howard A. Burris III,Bei Wang,E. Claire Dees,Javier Cortes,Amita Joshi,Manish Gupta,Joo-Hee Yi,Yu-Waye Chu,Ted Shih,Liang Fang,Sandhya Girish
T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial
Journal: Reviews on Recent Clinical Trials
Volume: 12 Issue: 3 Year: 2017 Page: 216-222
Author(s): Alicia FC Okines
Comparative Binding Analysis of Monoclonal Antibodies Against Native and Mutant Type in ErbB2 Receptor: A Theoretical Modeling Approach
Journal: Current Pharmaceutical Biotechnology
Volume: 10 Issue: 7 Year: 2009 Page: 701-708
Author(s): R. Rajasekaran, Sethumadhavan Rao
Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Journal: Reviews on Recent Clinical Trials
Volume: 10 Issue: 2 Year: 2015 Page: 82-89
Author(s): Matias E. Valsecchi,Enrique Diaz-Canton
Anti-HER2 Therapy in Elderly Breast Cancer Patients
Journal: Reviews on Recent Clinical Trials
Volume: 9 Issue: 4 Year: 2014 Page: 263-266
Author(s): Masataka Sawaki
HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007
Neoadjuvant Therapy for HER2-positive Breast Cancer
Journal: Reviews on Recent Clinical Trials
Volume: 12 Issue: 2 Year: 2017 Page: 81-92
Author(s): Rachel Wuerstlein,Nadia Harbeck
Anti-HER2 Cancer Therapy and Cardiotoxicity
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 4911-4919
Author(s): Tania Babar, Christopher Blomberg, Eileen Hoffner, Xinhua Yan
Monoclonal Antibodies and Antibody-drug Conjugates as EmergingTherapeutics for Breast Cancer Treatment
Journal: Current Drug Delivery
Volume: 21 Issue: 7 Year: 2024 Page: 993-1009
Author(s): Sachin Kumar Singh
HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2008 Page: 488-496
Author(s): Christian Widakowich, Phuong Dinh, Evandro de Azambuja, Ahmad Awada, Martine Piccart-Gebhart